Add to calendar
Seminar
Neurobinar #7 : April 29th at 4 pm on Zoom
For this fourth neurobinar of 2021, come and discover the work of Jean-Christophe Roux (MMG), Benoît Drouillas (INT) and Nicolas Hugues (INMED). Register on this page to receive the webinar connection link.
Want to take a break to get to know your colleagues?
On April 29 at 4 pm, come and discover the work of Jean-Christophe Roux (MMG), Benoît Drouillas (INT) and Nicolas Hugues (INMED). Benoît Drouillas and Nicolas Hugues will introduce their respective PhD in a cross-presentation. After a question session for PhD students, Jean-Christophe Roux will share with us his research on the optimization of gene therapy in Rett Syndrome.
Format
A one-hour web conference in 2 parts: two PhD students will give a 10 min cross-presentation of their PhD work. After 5 min of questions, they will hand over to a researcher, a postdoc or an engineer from the neuroscience community who will present in 20 min an accessible version of their research. Once again, you will have the opportunity to ask questions, debate on the topic of the day or simply get to know your colleague better!
Sign up below to receive the Zoom link!
The "Zoomers" on 29th April
Log in and learn more about the PhD of Benoît Drouillas (INT) presented by Nicolas Hugues (INMED) and vice versa. The presentation of both PhDs will be followed by the presentation of the work of Jean-Christophe Roux (MMG). You will also have the opportunity to ask your questions and review the Neurobinar on our YouTube Channel.
Jean-Christophe RouxTeam website
Jean-Christophe ROUX (MMG) achieved his academic education at Claude Bernard University in Lyon (France), where he obtained a PhD in Physiology. As a postdoc at the Karolinska Institute, he participated in research on the development of respiratory control at birth and how environmental perturbations could affect it. In the human neurogenetics team led by Dr Laurent Villard, Jean-Christophe Roux is in charge of Rett Syndrome and associated pathologies since 2006. Rett syndrome is a devastating genetic disorder (Mecp2 mutation) leading to autonomic and cognitive deficits that worldwide represents the second most common genetic cause of severe intellectual disability in females. His group is studying mouse models of Mecp2 dysfunctions and his work led to the implementation of two clinical trials (phase 2a) with Rett patients. The first trial deals with the stimulation of the monoaminergic neurotransmission and the second with the trophic support. Recently, he has developed innovative approaches using gene therapy targeting the brain.
Nicolas Hugues Impacts of various endurance exercise regimens and effects of their combination with cognitive training on neuroplasticity after cerebral ischemia
Almost 2 years ago, I gratuated a Master's degree in Human Movement Sciences from Marseille Sport Sciences Faculty. Since then, I'm carrying out my thesis project entitled "Impacts of various endurance exercise regimens and effects of their combination with cognitive training on neuroplasticity after cerebral ischemia". This project is supervised by Pr. Éric Berton and Jérôme Laurin at INMED (Mediterranean Neurobiology Institute).
Benoît Drouillas Differential contribution of Nav1.1 and Nav1.6 channels to bistable properties within the lumbar spinal locomotor network.
Benoît Drouillas started a degree in genetics and discovered neurosciences during an optional course. He then decided to do a degree in cognitive neuroscience in Marseille. Curious about cellular mechanisms, he went on to do a master's degree in neurobiology, neurophysiology and neuropathology in Marseille, after which he started his thesis. He is currently in the 3rd year of his thesis at the Institut de Neurosciences de la Timone. Supervised by Frédéric Brocard in the P3M team (plasticity and physiopathology of rhythmic motor networks), he is interested in the spinal cord network responsible for the development of locomotion.
Comments
